FO
BLUE

FT Options’s bluebird bio BLUE Stock Holding History

FT Options’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$176K Buy
+772
New +$1.08M 0.27% 70
2017
Q1 		– Sell
-1,992
Closed -$2K – 295
2016
Q4 		$2K Sell
1,992
-965
-33% -$766K ﹤0.01% 229
2016
Q3 		$68K Buy
2,957
+965
+48% +$699K 0.05% 185
2016
Q2 		$5K Sell
1,992
-309
-13% -$175K ﹤0.01% 307
2016
Q1 		$45K Sell
2,301
-3,319
-59% -$2.04M 0.05% 168
2015
Q4 		$87K Buy
+5,620
New +$5.61M 0.06% 136

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

FT Options's BLUE Position: Q3 2016 in Review

FT Options sold out of bluebird bio (BLUE) in Q3 2016, closing a stake of 97 shares — an estimated $70.3K sold.

FT Options first reported a position in BLUE in Q4 2015 and held it in 2 quarters. The position peaked at $644K in Q4 2015. 200 funds tracked by Wall St. Rank hold BLUE as of Q3 2016.

  • FT Options reported no remaining bluebird bio position as of Q3 2016 after selling out during the quarter.
  • FT Options sold 97 bluebird bio shares in Q3 2016, an estimated $70.3K.
  • FT Options first reported a position in bluebird bio in Q4 2015 and held it in 2 quarters.
  • FT Options's bluebird bio position peaked at $644K in Q4 2015.
  • 200 funds tracked by Wall St. Rank held bluebird bio as of Q3 2016.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.